Frontiers in adjuvant therapy in stage II-III melanoma

被引：0
|
作者：
Eggermont, AMM [1 ]
机构：
[1] Univ Rotterdam Hosp, Dr Daniel Den Hoed Canc Ctr, Dept Surg Oncol, NL-3075 EA Rotterdam, Netherlands
来源：
TUMORI JOURNAL | 2001年 / 87卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S60 / S63
页数：4
相关论文
共 50 条
  • [41] French dermatologists' opinions and practices with regard to adjuvant therapy in stage III melanoma
    Rolland, Marion
    Oger, Emmanuel
    Dinulescu, Monica
    Lesimple, Thierry
    Russo, David
    Pracht, Marc
    Porneuf, Marc
    Dalac, Sophie
    Giacchero, Damien
    Jouary, Thomas
    Lebbe, Celeste
    Leccia, Marie-Therese
    Maubec, Eve
    Meyer, Nicolas
    Mortier, Laurent
    Dupuy, Alain
    JEADV CLINICAL PRACTICE, 2023, 2 (04): : 708 - 717
  • [42] Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic Era
    Song, Y.
    Sun, J.
    Straker, R.
    Bruce, A. N.
    Cohen, L.
    Muradova, E.
    Daou, H.
    Sondak, V. K.
    Wuthrick, E.
    Zager, J. S.
    Lukens, J. N.
    Karakousis, G. C.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S154 - S155
  • [43] Clinical Outcomes in Stage III Cutaneous Melanoma Treated With Adjuvant Radiation Therapy
    Mathen, P.
    Debenham, B. J.
    Voroney, J. P.
    Banerjee, R. N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E714 - E714
  • [44] Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic Era
    Richard J. Straker
    Yun Song
    James Sun
    Adrienne B. Shannon
    Leah S. Cohen
    Elnara Muradova
    Hala Daou
    Kate Krause
    Siming Li
    Dennie T. Frederick
    Kristen E. Rhodin
    David M. Brizel
    Genevieve M. Boland
    Georgia M. Beasley
    Evan J. Wuthrick
    Vernon K. Sondak
    Jonathan S. Zager
    Alexander Lin
    John N. Lukens
    Giorgos C. Karakousis
    Annals of Surgical Oncology, 2021, 28 : 3512 - 3521
  • [45] Targeted Therapy for the Adjuvant Treatment of Stage III BRAF-Mutated Melanoma
    Long, Georgina
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (01) : 25 - 27
  • [46] Retrospective analysis of safety and efficacy of enhanced recovery pathways in stage II-III colorectal cancer patients submitted to surgery and adjuvant therapy
    Wang, Baoxin
    Wu, Zhenming
    Zhang, Rui
    Chen, Yue
    Dong, Jiuxing
    Qi, Xiuheng
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [47] Cyclin E as a prognostic marker and predictor of response to neoadjuvant chemotherapy and adjuvant hormonal therapy in patients with stage II-III breast cancer
    Karakas, Cansu
    Francis, Ashleigh
    Yi, Min
    Sahin, Aysegul
    Keyomarsi, Khandan
    Hunt, Kelly
    CANCER RESEARCH, 2015, 75
  • [48] Is adjuvant chemotherapy beneficial for stage II-III goblet cell carcinoid/goblet cell adenocarcinoma of the appendix?
    Zakka, Katerina
    Williamson, Shayla
    Jiang, Renjian
    Reid, Michelle D.
    Alese, Olatunji B.
    Shaib, Walid L.
    Wu, Christina
    Behera, Madhusmita
    El-Rayes, Bassel F.
    Akce, Mehmet
    SURGICAL ONCOLOGY-OXFORD, 2021, 36 : 120 - 129
  • [49] Analysis of the efficacy and factors influencing survival of adjuvant radiotherapy for stage II-III biliary tract carcinoma
    Guo, Yan-Ling
    Guo, Jia-Xing
    Zhao, Jian-Guo
    Bao, Ying-Na
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [50] Improving survival of stage II-III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy
    Li, Yang
    Zhu, Zhikai
    Ma, Fuhai
    Xue, Liyan
    Tian, Yantao
    CANCER MEDICINE, 2020, 9 (18): : 6617 - 6628
12345